NCT01189435 Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib Status TERMINATED Phase PHASE2
NCT01188746 Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites Status COMPLETED Phase NA
NCT01186705 Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer Status TERMINATED Phase PHASE2
NCT01186367 Trial Comparing the Effects of Linear Versus Nonlinear Aerobic Training in Women With Operable Breast Cancer Status COMPLETED Phase NA
NCT01183897 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow Status COMPLETED Phase PHASE2
NCT01183884 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma Status TERMINATED Phase PHASE2
NCT01183429 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Non-Myeloablative Therapy in Patients With High-Risk Neuroblastoma Status COMPLETED Phase PHASE2
NCT01183416 High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell Transplantation Status COMPLETED Phase PHASE2
NCT01183065 Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) Status COMPLETED Phase PHASE2
NCT01182506 Rehabilitation of Cognitive Changes in Breast Cancer Survivors Status ACTIVE_NOT_RECRUITING Phase NA
NCT01182168 Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT01181648 Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life Status COMPLETED Phase N/A
NCT01180569 Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma Status WITHDRAWN Phase PHASE1/PHASE2
NCT01169649 Study of MK-2206 in Patients With Metastatic Neuroendocrine Tumors (NET) Status COMPLETED Phase PHASE2
NCT01163448 Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic Cancer Status WITHDRAWN Phase PHASE1
NCT01157767 Exercise Program of Breast Cancer Patients Undergoing Chemotherapy With or Without Radiation Status COMPLETED Phase N/A
NCT01141309 Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01140373 Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01136005 Bepanthen Versus Cetomacrogol in Epidermal Growth Factor Receptor Inhibitors (EGFRI) Status COMPLETED Phase PHASE3